References
- Sugarman JM, Rodgers GC, Paul RI. Utility of toxicology screening in a pediatric emergency department. Pediatr Emerg Care. 1997;13:194–197.
- Belson MG, Simon HK. Utility of comprehensive toxicologic screens in children. Am J Emerg Med. 1999;17:221–224.
- Belson MG, Simon HK, Sullivan K, et al. The utility of toxicologic analysis in children with suspected ingestions. Pediatr Emerg Care. 1999;15:383–387.
- Montague RE, Grace RF, Lewis JH, et al. Urine drug screens in overdose patients do not contribute to immediate clinical management. Ther Drug Monit. 2001;23:47–50.
- von Mach MA, Weber C, Meyer MR, et al. comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting to an emergency department. Ther Drug Monit. 2007;29:27–39.
- Tenenbein M. Do you really need that emergency drug screen? Clin Toxicol (Phila). 2009;47:286–291.
- Hoffman RJ, Nelson L. Rational use of toxicology testing in children. Curr Opin Pediatr. 2001;13:183–188.
- Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83:66–76.
- Eskridge KD, Guthrie SK. Clinical issues associated with urine testing of substances of abuse. Pharmacotherapy. 1997;17:497–510.
- Petrie M, Lynch KL, Ekins S, et al. Cross-reactivity studies and predictive modeling of "bath salts" and other amphetamine-type stimulants with amphetamine screening immunoassays. Clin Toxicol. 2013;51:83–91.
- Fitzgerald RL, Rexin DA, Herold DA. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin Chem. 1994;40:373–380.
- Cotton SW, Duncan DL, Burch EA, et al. Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay. Clin Biochem. 2012;45:605–609.
- la Porte CJ, Droste JA, Burger DM. False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin. Ther Drug Monit. 2006;28:286.
- Rogers SC, Pruitt CW, Crouch DJ, et al. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity. Pediatr Emerg Care. 2010;26:665–666.
- King AM, Pugh JL, Menke NB, et al. Nonfatal tramadol overdose may cause false-positive phencyclidine on emit-II assay. Am J Emerg Med. 2013;31:444.e5–444.e9.
- Ly BT, Thornton SL, Buono C, et al. False-positive urine phencyclidine immunoassay screen result caused by interference by tramadol and its metabolites. Ann Emerg Med. 2012;59:545–547.
- Macher AM, Penders TM. False-positive phencyclidine immunoassay results caused by 3,4 methylenedioxypyrovalerone (MDPV). Drug Test Anal. 2013;5:130–132.
- Matos ME, Burns MM, Shannon MW. False-positive tricyclic antidepressant drug screen results leading to the diagnosis of carbamazepine intoxication. Pediatrics. 2000;105:E66.
- Dasgupta A, Wells A, Datta P. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine. Ther Drug Monit. 2007;29:134–139.
- Yuan CM, Spandorfer PR, Miller SL, et al. Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose. Ther Drug Monit. 2003;25:299–304.
- Gilbert EH, Lowenstein SR, Koziol-McLain, et al. Chart reviews in emergency medicine research: what are the methods? Ann Emerg Med. 1996;27:305–308.